NAP1L4 in hepatocellular carcinoma progression and treatment from gene expression to clinical impact
{{output}}
Background: Hepatocellular carcinoma (HCC) remains one of the deadliest malignancies globally, posing substantial health threats and economic burdens. Despite advances in therapeutic modalities-including surgical resection, liver... ...
